Cargando…

An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice

BACKGROUND: Respiratory syncytial virus (RSV) is a leading viral respiratory pathogen in infants. The objective of this study was to generate RSV live-attenuated vaccine (LAV) candidates by removing the G-protein mucin domains to attenuate viral replication while retaining immunogenicity through des...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roe, Molly K, Perez, Maria A, Hsiao, Hui-Mien, Lapp, Stacey A, Sun, He-Ying, Jadhao, Samadhan, Young, Audrey R, Batista, Yara S, Reed, Ryan C, Taz, Azmain, Piantadosi, Anne, Chen, Xuemin, Liang, Bo, Koval, Michael, Snider, Timothy A, Moore, Martin L, Anderson, Evan J, Anderson, Larry J, Stobart, Christopher C, Rostad, Christina A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796166/ https://www.ncbi.nlm.nih.gov/pubmed/36281651 http://dx.doi.org/10.1093/infdis/jiac382

Ejemplares similares

Detection of RSV Antibodies in Human Plasma by Enzyme Immunoassays
por: Jadhao, Samadhan J., et al.
Publicado: (2016)

Two RSV Platforms for G, F, or G+F Proteins VLPs
por: Ha, Binh, et al.
Publicado: (2020)

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation
por: Stobart, Christopher C., et al.
Publicado: (2016)

Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice
por: Caidi, Hayat, et al.
Publicado: (2012)

Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice
por: Rey, Gertrud U., et al.
Publicado: (2013)

Immunogenicity of RSV F DNA Vaccine in BALB/c Mice
por: Eroglu, Erdal, et al.
Publicado: (2016)

Effect of Infant RSV Infection on Memory T Cell Responses at Age 2-3 Years
por: Chirkova, Tatiana, et al.
Publicado: (2022)

Safety and Immunogenicity of a Live Attenuated RSV Vaccine in Healthy RSV-Seronegative Children 5 to 24 Months of Age
por: Malkin, Elissa, et al.
Publicado: (2013)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
por: Bergeron, Harrison C., et al.
Publicado: (2022)

260. Durability of Antibody Responses to RSV in Older Adults Following Hospitalization for Acute Respiratory Infection
por: Ciric, Caroline, et al.
Publicado: (2023)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
por: Hause, Anne M., et al.
Publicado: (2017)

Acteoside attenuates RSV-induced lung injury by suppressing necroptosis and regulating metabolism
por: Ling, Xiaoying, et al.
Publicado: (2022)

2621. Social Risk Factors for RSV-related Hospitalizations in Adults ≥ 50 years of age
por: De Castro, Khalel, et al.
Publicado: (2023)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
por: Hause, Anne M., et al.
Publicado: (2017)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
por: Cox, Freek, et al.
Publicado: (2023)

RSV attenuates epithelial cell restitution by inhibiting actin cytoskeleton-dependent cell migration
por: Linfield, Debra T., et al.
Publicado: (2021)

An outbreak of RSV infections in a neonatology clinic during the RSV-season
por: Vakrilova, Liliya, et al.
Publicado: (2021)

Compliance with RSV prophylaxis: Global physicians’ perspectives
por: Anderson, Kari S, et al.
Publicado: (2009)

Immunopathology of RSV: An Updated Review
por: Bergeron, Harrison C., et al.
Publicado: (2021)

1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023)

Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine
por: Groppo, Rachel, et al.
Publicado: (2018)

2777. Live-Attenuated Vaccine Against RSV Generates Robust Cellular and Humoral Immune Responses
por: Mueller, Steffen, et al.
Publicado: (2019)

RSV Disease: Current Management and the Future of Treatment and Prevention
por: Krilov, Leonard R., et al.
Publicado: (2021)

A Contemporary View of Respiratory Syncytial Virus (RSV) Biology and Strain-Specific Differences
por: Pandya, Mansi C., et al.
Publicado: (2019)

Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
por: Nederend, Maaike, et al.
Publicado: (2020)

Strategic priorities for respiratory syncytial virus (RSV) vaccine development
por: Anderson, L.J., et al.
Publicado: (2013)

Emergency Department Septic Screening in Respiratory Syncytial Virus (RSV) and Non-RSV Bronchiolitis
por: Chee, Chris, et al.
Publicado: (2010)

Prevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season
por: Van Der Plas, Johan L., et al.
Publicado: (2019)

Pathobiology of Respiratory Syncytial Virus (RSV)
por: Tripp, Ralph A., et al.
Publicado: (2020)

Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development
por: Boyoglu-Barnum, Seyhan, et al.
Publicado: (2019)

Immunity to RSV in Early-Life
por: Lambert, Laura, et al.
Publicado: (2014)

Severe Rhabdomyolysis Associated With RSV
por: Bender, James, et al.
Publicado: (2017)

Nasal Microbiota in RSV Bronchiolitis
por: Schippa, Serena, et al.
Publicado: (2020)

Respiratory Syncytial Virus (RSV)
por: Walsh, Edward E., et al.
Publicado: (2015)

Socioeconomic Impact of RSV Hospitalization
por: Young, Michal, et al.
Publicado: (2021)

Clinical severity of RSV bronchiolitis
por: Hussain, Faris, et al.
Publicado: (2022)

Prediction of serious RSV‐related outcomes in older adults with outpatient RSV respiratory illness during 12 consecutive seasons
por: Kieke, Burney A., et al.
Publicado: (2020)

Effects of Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) in the Perinatal Lamb Model of RSV
por: Derscheid, Rachel J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k05c4h00csf3kvgr5jer5osdg9